Amanote Research
Register
Sign In
Are the Effects of Drugs to Prevent and to Treat Heart Failure Always Concordant? The Statin Paradox and Its Implications for Understanding the Actions of Antidiabetic Medications
European Journal of Heart Failure
- United States
doi 10.1002/ejhf.1183
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cardiovascular Medicine
Cardiology
Date
March 22, 2018
Authors
Milton Packer
Publisher
Wiley
Related search
Recommendations for the Conduct of Clinical Trials for Drugs to Treat or Prevent Sarcopenia
Aging clinical and experimental research
Aging
Gerontology
Geriatrics
Interventions to Prevent Heart Failure Readmissions: The Rationale for Nurse-Led Heart Failure Programs
Journal of Nursing Education and Practice
Managing the Oral Side-Effects of Medications Used to Treat Multiple Sclerosis
Australian Dental Journal
Dentistry
Progress and Challenge of Cardiac Regeneration to Treat Heart Failure
Journal of Cardiology
Cardiovascular Medicine
Cardiology
Obesity in Heart Failure: Is It Time to Rethink the Paradox?
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Meta-Analysis, Simpson's Paradox, and the Number Needed to Treat
BMC Medical Research Methodology
Epidemiology
Health Informatics
Obesity in Heart Failure: Is It Time to Rethink the Paradox? Reply
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
7. Diabetes and Heart Failure: How to Treat Doubles Dangers
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
Failure of Antiarrhythmic Drugs to Prevent Experimental Reperfusion Ventricular Fibrillation
Circulation
Cardiovascular Medicine
Physiology
Cardiology